MGT001
BloodNet Fresh Blood Product Management
Report
Specification
MGT001 - Fresh Blood Product Management Report
Page 2
Version Control
Version Revision Date Revision Description
0.1 07/07/2014 Initial Draft.
0.2 04/08/2014 Changed after feedback.
0.3 22/08/2014 Major modifications based on producing the report soley for Print and for a single
AHP
0.4 26/08/2014 Minor modifications after feedback from Sandra C.
0.5 20/01/2015 Additional sections added, explanation of Stock On hand calculation added
Creative Commons
With the exception of any logos and registered trademarks, and where otherwise noted, all material presented
in this document is licensed by the NBA under a Creative Commons Attribution 3.0 Australia
(http://creativecommons.org/licenses/by/3.0/au/) licence. In essence this licence allows you to copy,
communicate and adapt the work, as long as you attribute the work to the National Blood Authority and abide
by the other licence terms.
MGT001 - Fresh Blood Product Management Report
Page 3
The details of the relevant licence conditions are available on the Creative Commons website (accessible using
the links provided) as is the full legal code for the CC BY 3.0 AU licence
(http://creativecommons.org/licenses/by/3.0/au/legalcode).
The content obtained from this document or derivative of this work must be attributed as the National Blood
Authority BloodNet PSO Report Specification.
MGT001 - Fresh Blood Product Management Report
Page 4
Contents
1. Introduction .................................................................................................................................... 5
1.1 Purpose ................................................................................................................................... 5
2. Report Details ................................................................................................................................. 6
2.1 Description .............................................................................................................................. 6
2.2 Business Rules ......................................................................................................................... 6
2.3 BloodNet Source Data ............................................................................................................. 7
2.4 FUL010e – Fresh Blood Orders and Issues .............................................................................. 7
2.5 FATE007 - Fresh Component Health Provider Discards .......................................................... 7
2.6 FATE007e – Fresh Component Health Provider Discards Extract ........................................... 7
3. Report Content ............................................................................................................................... 8
3.1 Parameters .............................................................................................................................. 8
3.2 Report Field Description ......................................................................................................... 9
3.3 Cover Page .............................................................................................................................. 9
3.4 Report Detail ......................................................................................................................... 10
7. Appendix A – Report Layout ......................................................................................................... 18
8. Appendix B – Component Groups ................................................................................................. 19
9. Appendix C - Fulfilment Matching................................................................................................ 20
MGT001 - Fresh Blood Product Management Report
Page 5
1. Introduction
1.1 Purpose
The purpose of this document is to describe the user specification for the BloodNet Fresh Blood
Product Management Report.
The purpose of the report is to allow facility administrators to view and monitor their fresh blood
demand and stock management
Fresh Blood Product Management Report
Page 6
2. Report Details
2.1 Description
A report to provide a high level view of various metrics of fresh blood products for inidvidual facilities on
BloodNet.
The report combines data already present in BloodNet reports as well as incorporating new data and
summaries.
The report covers Fresh Blood Products distributed by the Blood Service.
2.2 Business Rules
1. For the purposes of fulfilment, identifing matching transactions between orders and issues the following
process takes place.
A. When making an order for Fresh Products, the AHP will select a Component(Id) + ABO +_ Rh. For
example
i. Red Cells O+
ii. Cryopreciptiate B+
B. When an order is filled by the Blood Service they provide a SupplierComponentIdentifier + ABO +
Rh. For example
i. 04250 – Red Cells in Optisol O+
ii. 12010 – Platelets Apheresis AB-
C. When BloodNet receives the Issue Note, the SupplierComponent is mapped to a Component so
that it can be matched with the order and fulfilment determined.
D. Supplier Components are also linked to CostGroups. Cost groups determine the cost of the product
supplied by the Blood service. For example
i. 04250 Red Cells in Optisol 2a WB Red Cell
ii. 12010 Platelets Apheresis 3d Apheresis Platelet - Leucodepleted
A full List of mappings for Component to Cost groups and (a sample of) Supplier Components can be
found in Appendix C
2. Component Groups
Just as Components and Supplier Components can be mapped to Cost Groups, there is also a
mapping to Component Groups. Using Component Groups allows the report to condense orders
and issues to a common derivative, and also allow further comparisons between orders and issues
when it comes to Fate and Orders.
A full list of component groups can be found in Appendix B
3. Supplier Faults.
MGT001 - Fresh Blood Product Management Report
Page 7
The following discard reasons are deemed to be faults that are attributable to the Supplier and out
of the control of the AHP, therefore play no part in the calculation of the DAPI (Discards as a
Percentage of Issues)
Supplier Fault Discard Reasons
i. Damaged – Supplier Transit
ii. Recall – By Supplier
iii. Transport – Temperature failure from supplier
iv. Transport – Incorrect packing from supplier
2.3 BloodNet Source Data
The data from BloodNet used to create this report match data presented in the reports below.
2.4 FUL010e – Fresh Blood Orders and Issues
Both the Issues and Orders tabs are used and can be used to reconcile a mixture of data in the report
2.5 FATE007 - Fresh Component Health Provider Discards The DAPI calculations are used. This report DAPI will will only be comparible Top level groups (highlighted below) appearing in FATE007 as Fate007 is based on Issued products
2.6 FATE007e – Fresh Component Health Provider Discards Extract
This extract presents the data that determines the results for FATE007. It lists individual transactions for issue,
transfers (in and out) and discards on separate tabs.
The information in FATE007e should also correlate with data in FATE001 and FATE003.
MGT001 - Fresh Blood Product Management Report
Page 8
3. Report Content
3.1 Parameters
The following parameters will be available and all are mandatory
Name Description Control Type Values/Value List Default Value
State All Australian States listed Drop down All States
All States
Health Provider All facilities, filtered by the State selected
above. The report can only be run for
one AHP within one State.
Drop down All available facilities <none>
Start Date Start date of the reporting period Date Picker Any valid Date <None>
End Date End Date of the Reporting Period
Validate the Start and End dates to
ensure there is no more than a years
worth of data to report, and the start
and end dates do not cross FY
Date Picker Any Valid Date <None>
MGT001 - Fresh Blood Product Management Report
Page 9
3.2 Report Field Description
The report will consist of up to 12 pages (or 18 pages if paediatrics are separated) and specifically designed to be
exported to PDF for printing and offline inspection. If there is no data for a specific component for the period,
then that component is not shown.
The following outlines the page numbers and contents if Report on Paediatric Separately
parameter is set to No
Page 1 – Cover Page
Pages 2/3 – Red Cells Adult
Pages 4/5 – Platelets Adult
Pages 6/7 – Clinical Fresh Frozen Plasma Adult
Pages 8/9 – Cryoprecipitate
Pages 10/11 – Cryodepleted Plasma
Page 12 – Back cover - BloodNet News. 2 latest news items relevant to the facility. These items are the same
as the first 2 currently displayed news items for the facility on the BloodNet home page. (note the report will
not show images within the news items as they are ignored by the reporting engine.
If Report on Paediatric Separately parameter is set to YES, then add the following pages
immediately after their corresponding component
Pages 3a/3b – Red Cells Paediatric
Pages 5a/5b – Platelets Paediatric
Pages 7a/7b – Clinical Fresh Frozen Plasma Paediatric
3.3 Cover Page
Data Description
Report Title Fresh Blood Management Report
Facility Name Health provider selected from parameter, include AHPCode
Start Date and End Dates of reports Show the parameters entered in long format, Eg. 1 July 2013 to 30 June 2014
MGT001 - Fresh Blood Product Management Report
Page 10
3.4 Report Detail
View Appendix A for the layout of Report parts.
The information below relates to the information presented for each Fresh Blood Product group on a double
page spread.
Summary Table
For each of the fields below, display the values for the selected date period
For each Component, each of the values below will be broken down into ABO and a total
Field Name Description
Average Age at Issue The average of the age at issue (determined by days between the date the component was collected and the date it was issued by the Blood Service)
Average Age at Transfusion
The average of the age at Transfusion (determined as days between Date Collected and Transfusion Date). Note: Only LIS enabled sites will have this information
Order Quantity The sum of the order quantity for finalised orders for the period. Includes Special and Stock Orders
Order Qty % of Total Orders
The amount ordered for this bloodgroup as a percentage of all blood groups for the period.
*Issued Quantity For each ABO, the issued quantity performed through *BloodNet for the period
Issue Qty % of Total Issues
For each ABO, the number issued for this bloodgroup as a percentage of all issues for the period.
Receipted Quantity The sum of the quantity reportedly receipted in BloodNet for the period
Transfers In The sum of the number of components transferred in to the facility for the period
Transfers Out The sum of the number of components transferred Out of the facility for the period
Net Issues A calculation = (Issued Quantity – Transfers Out + Transfers In)
ǂ Discards The sum of the number of discards for each component/ABO for the period. ǂ note this figure excludes discards that were caused by the supplier – see Supplier Faults)
ǂ DAPI Discards as a Percentage of Net Issues. A calculation of Discards/Net Issues. ǂ Note the calculation for DAPI in this field excludes discards that were caused by the Supplier – see Supplier Faults)
(Excluding Transfers) ǂ DAPI
Discards as a Percentage of Net Issues excluding Transfers. The purpose of this value it to remove the effect of transfers when calculating the DAPI. (i.e. some hospitals get transfers of stock when the stock is close to expiry. Often this stock is then discarded which has the effect of increasing the DAPI for the hospital. This value aims to remove that effect by:
If a Component was transferred In (In this period) and subsequently discarded (at any time), the component is removed from the NetIssues before calculating DAPI
If a component was discarded in this period, but previously transferred in (at any time) the component is removed from the Discards before calculating the DAPI
ǂ Note the calculation for DAPI in this field also excludes Supplier Faults
(Expired Discards Only) ǂ DAPI
Discards as a Percentage of Net Issues. A calculation of Discards/Net Total Issues. ǂ Note the calculation for DAPI in this report only includes discards that have a discard reason of Expired – Time Expired
% Issued (or Ordered) Sum of Issued Qty / Sum of Order Qty
% Receipted (of Issued)
Sum of Receipted Qty / Sum of Issued Qty
MGT001 - Fresh Blood Product Management Report
Page 11
Orders
Field Name Description
Special Order Quantity Stock Order Quantity
Order Qty – sum of units ordered from special orders Order Qty – sum of units ordered from stock orders
Total Total number of stock and special orders and the % of Stock vs Special
MGT001 - Fresh Blood Product Management Report
Page 12
Order Types
This table displays the number of Orders at each priority (Standard, Urgent, Life Threatening) for Stock and
Special Orders as well as the quanties of each component ordered at each priority. Counts only include finalised
orders where the OrderQty > 0
Special Orders
Stock Orders
Total Orders
Special Order Qty
Stock Order Qty
Total Order Qty
Life Threatening
Urgent
Standard
Total
Units Issued and DAPI Chart
Display a chart with 4 separate series
2 Bar chart series showing the number of fresh products issued for each month during the period
and the same period 12 months earlier
2 Line Charts showing each showing the respective DAPI for each month within the selected period,
and the same period 12months earlier. Display the DAPI value above each series for each month.
MGT001 - Fresh Blood Product Management Report
Page 13
Inventory Level Chart
Display a line graph showing Average Stock on Hand, Max Stock and Order Quantity for each day. Only display
values for finalised stock orders (special orders take no part in this chart) and values displayed correlate with
INV010.
Note: the stock on hand figure needs to be extrapolated from previously entered data, with the assumption
being ‘Stock On Hand doesn’t change if there is no entry to state otherwise’
Eg – Using the following subset of orders to illustrate the point.
Orders are placed for Red Cells Irradiated on July 1,4 and 5, because there was no Stock on Hand entered for
July 2,3 and 6, these figures are derived from the previous entry (light grey being derived figures used in the
calculation in the chart).
Note that even though there was an order on the 4th, there was no Stock on Hand entered with the order, so
the derived value is used from the previous entry.
Order Date Product Order Qty Stock On Hand
1 July Red Cells Irradiated 3 5
2 July Red Cells Irradiated 0 5
3 July Red Cells Irradiated 0 5
4 July Red Cells Irradiated 7 <Not Entered> 5
5 July Red Cells Irradiated 9 0
6 July Red Cells Irradiated 0 0
MGT001 - Fresh Blood Product Management Report
Page 14
Age at Issue Chart
Display a chart showing the age at issue for the fresh component for the Facility. Overlay the State and National
values for comparison.
The Facility data is shown as a barchart with the height indicating the PERCENT issued, for the product at that
age over all products issued during that time.
For each age of product display the total number of issues as well as the percentage as part of the chart.
Eg if 10 red cells were issued @ 2 days old, but the total issue for the period for Red Cells was 100 Red
Cells (of any age), the barchart would show 10%.
Above each column, show the percentage and total issues for each age
The age at issue is presented in days or months (depending on the fresh component) and presented as a range
of ages banded together along the y axis. The Banding has been determined based on expected age of fresh
component at usage. Banding is described further in Appendix D
For very small percentages (less than 0.5% of the total) the text above each column is not shown. This issue (as
well as rounding anomalies) may cause the total of the percentages display to differ from 100%
If the banding is displayed in Months, each month equates to 30 days
1 month = 0-30 days old
2 months = 31-60 days old
3 months = 61-90 days old, etc
MGT001 - Fresh Blood Product Management Report
Page 15
Age at Transfusion Chart
For LIS enabled facilities this graph appears similar to the Age at Issue but for transfusion data (number of days
between Collection Date and Transfusion date). If the AHP is not LIS interfaced the space will be used for
promotional material to get AHPs to integrate their LIS.
Some Issues do not have Collection Date (previous to 2012) in this instance the collection date is assumed to be
the same as the issue date
For very small percentages (less than 0.5% of the total) the display the text above each age is not shown.
If the banding is displayed in Months, each month equates to 30 days
1 month = 0-30 days old
2 months = 31-60 days old etc
MGT001 - Fresh Blood Product Management Report
Page 16
Order Fulfilment Chart
Histogram of Orders vs Issues. The X-axis is ABO with the Y-Axis as difference in Order and Issues quantity. The
difference between Ordered Quantity and Issued Quantity and that difference as as a percentage is included
above each bar. This is for Stock orders only that are finalised. A line showing the average difference between
orders and issues is also displayed on this graph.
Discard by Reason Chart
A horizontal bar chart showing the reasons for discards.
The Y-axis is Discard Reason with the X-Axis as Number of Discards. The number of discards is displayed at the
end of each bar, along with a percentage of total discards for the period.
If a discard reason was not used during the period it will not appear.
Supplier faults (section 2.2.3) discards are displayed in a different colour hightlight the differences.
MGT001 - Fresh Blood Product Management Report
Page 17
DAPI by ABO Chart
Stacked Bar chart of DAPI. The chart is stacked with Supplier Faults and all-other Discard Reasons, and the total
DAPI correlate with the summary table.
The X-axis is ABO split into the selected FY and the previous FY. The Y-Axis and labels are DAPI percentages for
each blood type.
DAPI Comparators Chart
Bar Chart of DAPI, where X–axis is the DAPI for the AHP, the States, the Peer Group (as defined in FATE007) and
the National comparators and the Y-Axis as percentages. The bars are labelled with the DAPI for the product
group.
If there is a target benchmark for the fresh product DAPI, it is displayed as a red line.
Fresh Blood Product Management Report
Page 18
7. Appendix A – Report Layout
Double page spread layout for product group showing layout from Page 2 onward
Page 1 Page 2
Table of key data for each blood group including
Average Age at Issue/Transfusion
Order /Issue/Receipted Qty
Transfers In/Out
Discards
Discards as a Perenctage of Net issued (DAPI)
DAPI (excluding Transfers)
DAPI (Expired components only)
Fulfilment – Orders vs Issues
Bar Chart
Graph –Age at transfusion (LIS enabled facilities) or Receipt to Issues %
Bar Chart
Age at Issue at facility by blood group
Bar Chart
Discard by reason
Horizontal Bar Chart
DAPI compared to organisation,
group, state, national
Bar Chart
Red Cells – Incl/Excl Paeds
Inventory level Chart (Line Chart)
Line graph of Stock on Hand by Product Group selected with line for Max
Agreed Stock, Ordered Qty and Stock On Hand
blood group
DAPI by ABO
Stacked Bar Chart
Units Issued and DAPI
Vertical Bar chart showing number of issues by Month. (current and
previous years). Overlay Line chart with DAPI (current and previous years)
Bar / Line Chart
Orders number of ordered components (special/stock) for each bloodType
Vertical Bar chart showing number of issues by Month. (current and
previous years). Overlay Line chart with DAPI (current and previous years)
Bar / Line Chart
Orders Types
Vertical Bar chart showing number of issues by Month. (current and
previous years). Overlay Line chart with DAPI (current and previous years)
Bar / Line Chart
Fresh Blood Product Management Report
Page 19
8. Appendix B – Component Groups
Component Name What can be ordered
Component Group Group by fresh product type
Condensed Component Group Incorporate Paediatrics into Group
Whole Blood Whole Blood Whole Blood
Red Cells Red Cells Red Cells
Red Cells Paediatric Red Cells Paediatric Red Cells
Platelets Pooled Platelets Platelets
Platelets Apheresis Platelets Platelets
Platelets Pooled Paediatric Platelets Paediatric Platelets
Platelets Apheresis Paediatric Platelets Paediatric Platelets
Fresh Frozen Plasma Clinical Fresh Frozen Plasma Clinical Fresh Frozen Plasma
Fresh Frozen Plasma Paediatric Clinical Fresh Frozen Plasma Paediatric Clinical Fresh Frozen Plasma
Cryoprecipitate Cryoprecipitate Cryoprecipitate
Cryoprecipitate Apheresis Cryoprecipitate Cryoprecipitate
Cryo-Depleted Plasma Cryo-depleted Plasma Cryo-depleted Plasma
MGT001 - Fresh Blood Product Management Report
Page 20
9. Appendix C - Fulfilment Matching
Component Component Group
Cost Group Supplier Component
Red Cells Red Cells 2a WB Red Cell 04210-RED CELLS IN ADSOL 04250-RED CELLS IN OPTISOL 04060-RED CELLS PREPARED FROM CPDA-1
Red Cells Red Cells 2b WB Red Cell - Leucodepleted 04310-RED CELLS IN ADSOL LEUCOCYTE DEPLETED 04311-RED CELLS IN ADSOL 1 OF 2 LEUCOCYTE DEPLETED 04312-RED CELLS IN ADSOL 2 OF 2 LEUCOCYTE DEPLETED
Red Cells Red Cells 2c WB Red Cell - Buffy Coat Poor 04610-RED CELLS IN ADSOL BUFFY COAT REMOVED 04650-RED CELLS IN OPTISOL BUFFY COAT REMOVED 04680-RED CELLS IN SAG-M BUFFY COAT REMOVED
Red Cells Red Cells 2e WB Washed Red Cell 04900-RED CELLS WASHED NO ADDITIVE 04910-RED CELLS WASHED IN ADSOL 04900-RED CELLS WASHED NO ADDITIVE
Red Cells Red Cells 2f WB Washed Red Cell - Leucodepleted 04800-RED CELLS LEUCOCYTE DEPLETED WASHED NO ADDITIVE 04801-RED CELLS 1 OF 2 LEUCOCYTE DEPLETED WASHED NO ADDITIVE 04802-RED CELLS 2 OF 2 LEUCOCYTE DEPLETED WASHED NO ADDITIVE
Red Cells Red Cells 2g Apheresis Red Cell - Leucodepleted 04381-RED CELLS IN SAG-M 1 OF 2 APHERESIS LEUCODEPLETED 04382-RED CELLS IN SAG-M 2 OF 2 APHERESIS LEUCODEPLETED 04381-RED CELLS IN SAG-M 1 OF 2 APHERESIS LEUCODEPLETED
Red Cells Paediatric Red Cells Paediatric
2d WB Paediatric Red Cell - Leucodepleted (1 of 4) 34311-RED CELLS IN ADSOL 1 OF 4 LEUCOCYTE DEPLETED PAEDIATRIC 34312-RED CELLS IN ADSOL 2 OF 4 LEUCOCYTE DEPLETED PAEDIATRIC 34313-RED CELLS IN ADSOL 3 OF 4 LEUCOCYTE DEPLETED PAEDIATRIC
Platelets Apheresis Platelets 3d Apheresis Platelet - Leucodepleted 12070-PLATELETS APHERESIS IN T-SOL 12071-PLATELETS APHERESIS 1 OF 2 IN T-SOL 12072-PLATELETS APHERESIS 2 OF 2 IN T-SOL
Platelets Pooled Platelets 3a WB Platelet 12000-PLATELETS 12900-PLATELETS WASHED 12001-PLATELETS 1 OF 2
Platelets Pooled Platelets 3b WB Platelet - Leucodepleted 12300-PLATELETS LEUCOCYTE DEPLETED 12321-PLATELETS POOLED IN T-SOL LEUCOCYTE DEPLETED 12320-PLATELET POOLED LEUCODEPLETED SSP+
Platelets Pooled Platelets 3c WB Platelet - Buffy Coat Poor 12021-PLATELETS POOLED IN T-SOL 12021-PLATELETS POOLED IN T-SOL 12021-PLATELETS POOLED IN T-SOL
Platelets Apheresis Paediatric
Platelets Paediatric
3e Paediatric Apheresis Platelet - Leucodepleted (1 of 4) 32641-PLATELETS 1 OF 4 PAEDIATRIC LEUCOCYTE DEPLETED 32642-PLATELETS 2 OF 4 PAEDIATRIC LEUCOCYTE DEPLETED 32643-PLATELETS 3 OF 4 PAEDIATRIC LEUCOCYTE DEPLETED
Fresh Frozen Plasma Clinical Fresh Frozen Plasma
4b WB Clinical FFP - Buffy Coat Poor 18200-FRESH FROZEN PLASMA 18201-FRESH FROZEN PLASMA 1 OF 2
MGT001 - Fresh Blood Product Management Report
Page 21
18202-FRESH FROZEN PLASMA 2 OF 2
Fresh Frozen Plasma Clinical Fresh Frozen Plasma
4d Apheresis Clinical FFP 18210-FRESH FROZEN PLASMA APHERESIS 18211-FRESH FROZEN PLASMA 1 OF 2 APHERESIS 18212-FRESH FROZEN PLASMA 2 OF 2 APHERESIS
Fresh Frozen Plasma Paediatric
Clinical Fresh Frozen Plasma Paediatric
4c Paediatric WB Clinical FFP (1 of 4) 18241-FRESH FROZEN PLASMA PAEDIATRIC 1 OF 4 18242-FRESH FROZEN PLASMA PAEDIATRIC 2 OF 4 18243-FRESH FROZEN PLASMA PAEDIATRIC 3 OF 4
Cryoprecipitate Cryoprecipitate 5a WB Cryoprecipitate 10100-CRYOPRECIPITATE 10100-CRYOPRECIPITATE 10100-CRYOPRECIPITATE
Cryoprecipitate Apheresis
Cryoprecipitate 5b Apheresis Cryoprecipitate 10110-CRYOPRECIPITATE APHERESIS 10110-CRYOPRECIPITATE APHERESIS 10110-CRYOPRECIPITATE APHERESIS
Cryo-Depleted Plasma Cryo-depleted Plasma
6a WB Cryo-depleted Plasma 18400-CRYO-DEPLETED PLASMA 18400-CRYO-DEPLETED PLASMA 18400-CRYO-DEPLETED PLASMA
Cryo-Depleted Plasma Cryo-depleted Plasma
6b Apheresis Cryo-depleted Plasma 18410-CRYO-DEPLETED PLASMA APHERESIS 18410-CRYO-DEPLETED PLASMA APHERESIS 18410-CRYO-DEPLETED PLASMA APHERESIS
MGT001 - Fresh Blood Product Management Report
Page 22
10. Appendix D – Component Age Banding.
The following table describes the bands used for each of the Fresh Blood Component age at issue banding (note that
these could be different from the Age At Transfusion banding)
Component Age At Issue Banding Age At Transfusion Banding
Red Blood Cells including Peadiatrics
0 (issued same day as collected) 1 through 29 days reported separately 30-34 35-39 40-42 >42 (Greater than 42 days old)
<5 (less than 5 days old) 5 through 34 days reported separately 35-39 > 40 days
Platelets including Peadiatrics
0 through 6 days reported separately 0 through 6 days reported separately
Clinical fresh Frozen Plasma including Peadiatrics
1 through 12 months reported monthly 1 through 12 months reported monthly
Cryoprecipitate 1 through 12 months reported monthly 1 through 12 months reported monthly
Cryo-depleted Plasma 1 through 12 months reported monthly 1 through 12 months reported monthly
Due to the quality of data, the age of a component can be negative or older than the longest usable age. In that
case, these values are attributed to the smallest and largest values respectively.